Verdiva Bio secures £333.5m in major funding round!
Deal News | Jan 10, 2025 | UK Tech Funding
In the year's first UK tech funding roundup for January 2025, various tech startups have attracted significant investment. Among the standout deals is Verdiva Bio, a London-based biotech company that secured £333.5m in a Series A round led by Forbion and General Atlantic. Founded in 2024, Verdiva Bio is targeting weight loss breakthroughs to rival popular treatments like Ozempic. Smartphone company Nothing, also from London, locked in a £30m debt financing deal with Santander. Known for consumer hardware, Nothing is moving into the smartphone arena. Health tech and AI company VitVio received a £1.5m pre-seed investment to enhance its computer vision tech for medical procedures, with support from LDV Capital and other investors. RoboK, an AI CCTV tech firm based in Cambridge, was awarded a £1m grant by UKRI to integrate AI algorithms into surveillance systems. Finally, London-based Mulder, a tech firm advancing blockchain in the medical supply chain, garnered £500,000 in pre-seed funding from SFC Capital and Innovate UK.
Sectors
- Biotech
- Consumer Electronics
- Health Tech
- AI
Geography
- United Kingdom – All the companies mentioned in the article are based in the UK, focusing on the regional tech funding scene.
Industry
- Biotech – Focused on Verdiva Bio, which is developing weight loss medication, indicative of the biotech industry.
- Consumer Electronics – Highlighted by Nothing's development of consumer hardware and smartphones.
- Health Tech – VitVio and Mulder are driving innovation in medical procedures and supply chains, contributing to the health tech industry.
- AI – Both VitVio and RoboK are leveraging AI in their technological solutions, reflecting AI applications.
Financials
- £333.5m – Funding raised in Series A by Verdiva Bio.
- £30m – Debt financing for Nothing.
- £1.5m – Pre-seed investment for VitVio.
- £1m – Grant awarded to RoboK by UKRI.
- £500,000 – Pre-seed funding secured by Mulder.
- £366.5m – Total UK tech investment tracked by UKTN for the week.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Verdiva Bio | Target company | Company | A London-based biotech company focusing on weight loss medications. |
| Nothing | Target company | Company | London-based consumer electronics company developing smartphones. |
| VitVio | Target company | Company | London-based health tech company specializing in AI for medical procedures. |
| RoboK | Target company | Company | Cambridge-based company integrating AI into CCTV technology. |
| Mulder | Target company | Company | Developing blockchain solutions for medical supply transparency, based in London. |
| Forbion | Investor | Company | Venture capital firm investing in Verdiva Bio. |
| General Atlantic | Investor | Company | Private equity firm involved in Verdiva Bio's Series A. |
| Santander | Investor | Company | Provided debt financing for Nothing. |
| LDV Capital | Investor | Company | Venture capital firm investing in VitVio. |
| Bek Ventures | Investor | Company | Investor in VitVio's pre-seed round. |
| Tiny Supercomputer Investment Company | Investor | Company | Investor in VitVio. |
| UKRI | Investor | Government | Provided grant funding to RoboK. |
| SFC Capital | Investor | Company | Investing in Mulder's blockchain initiative. |
| Innovate UK | Investor | Government | Supporting Mulder with pre-seed financing. |